# OrphanCure Full Pipeline Report: repodb_1ec6c8c3ab8e153d

- Drug: Famotidine
- Disease: Duodenal Ulcer
- Mode: full
- Status: completed
- Final assessment: Valid

This generated report is for research support only and is not medical advice.

## Structured Output

```json
{
  "sections": {
    "1_executive_summary": {
      "conclusion": "Valid",
      "confidence": "High",
      "summary": "Famotidine is a histamine H2 receptor antagonist that reduces gastric acid secretion. This mechanism is directly relevant to the treatment of duodenal ulcers, as evidenced by its inclusion in clinical trials and studies evaluating ulcer recurrence and protective effects. The literature supports famotidine's efficacy and safety in this context.",
      "evidence_counts": {
        "total_papers": 9,
        "supporting": 7,
        "contradicting": 0,
        "inconclusive": 2
      },
      "common_targets_count": 1
    },
    "2_normalized_hypothesis": {
      "statement": "Repurpose FAMOTIDINE for duodenal ulcer",
      "drug": {
        "id": "CHEMBL902",
        "name": "FAMOTIDINE",
        "aliases": [
          "Pepcid",
          "Famotidine acetate",
          "Famotidine hydrochloride",
          "Famosan",
          "Gaster"
        ],
        "resolution_method": "auto"
      },
      "disease": {
        "id": "EFO_0004607",
        "name": "duodenal ulcer",
        "aliases": [
          "ulcer of duodenum",
          "duodenal peptic ulcer",
          "duodenal ulcer disease",
          "ulcer, duodenal",
          "duodenal ulcer NOS"
        ],
        "resolution_method": "auto"
      }
    },
    "3_mechanistic_rationale": {
      "total_mechanisms": 1,
      "mechanisms": [
        {
          "target": "HRH2",
          "drug_action": "ANTAGONIST",
          "disease_score": 0.582,
          "pathway": "Famotidine inhibits histamine binding to histamine H2 receptors (HRH2) on parietal cells, thereby reducing gastric acid secretion and allowing duodenal ulcers to heal."
        }
      ]
    },
    "4_target_overlap_summary": {
      "total_overlapping": 1,
      "top_targets": [
        {
          "symbol": "HRH2",
          "name": "histamine receptor H2",
          "drug_action": "ANTAGONIST",
          "disease_association_score": 0.582
        }
      ]
    },
    "5_literature_evidence_summary": {
      "total_retrieved": 9,
      "polarity": {
        "supports": 7,
        "contradicts": 0,
        "inconclusive": 2
      },
      "support_ratio": "7 of 9 retrieved papers support the hypothesis",
      "queries_used": 11,
      "top_papers": [
        {
          "pmid": "37206569",
          "title": "Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non\u2011eradication treatment of duodenal ulcer: A network meta\u2011analysis.",
          "year": "2023",
          "relevance_score": 10.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Clinical study",
            "Recent"
          ]
        },
        {
          "pmid": "39193965",
          "title": "Neuroprotective Effect of Famotidine in Mouse Models of Alzheimer's Disease.",
          "year": "2024",
          "relevance_score": 7.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent"
          ]
        },
        {
          "pmid": "35002587",
          "title": "Protective Effects of Phoenixin-14 Peptide in the Indomethacin-Induced Duodenal Ulcer: An Experimental Study.",
          "year": "2022",
          "relevance_score": 6.5,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Recent"
          ]
        },
        {
          "pmid": "31229990",
          "title": "Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.",
          "year": "2020",
          "relevance_score": 6.0,
          "polarity": "SUPPORTS",
          "match_reasons": []
        },
        {
          "pmid": "38576803",
          "title": "Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report.",
          "year": "2024",
          "relevance_score": 6.0,
          "polarity": "SUPPORTS",
          "match_reasons": [
            "Case report limit",
            "Recent"
          ]
        },
        {
          "pmid": "30666204",
          "title": "Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis.",
          "year": "2018",
          "relevance_score": 5.5,
          "polarity": "INCONCLUSIVE",
          "match_reasons": [
            "Clinical study"
          ]
        },
        {
          "pmid": "26883979",
          "title": "Gastroprotective effects of several H2RAs on ibuprofen-induced gastric ulcer in rats.",
          "year": "2016",
          "relevance_score": 4.0,
          "polarity": "SUPPORTS",
          "match_reasons": []
        },
        {
          "pmid": "32408271",
          "title": "Hyponatremia presenting with hourly fluctuating urine osmolality.",
          "year": "2020",
          "relevance_score": 3.0,
          "polarity": "INCONCLUSIVE",
          "match_reasons": []
        },
        {
          "pmid": "28924528",
          "title": "Near-Fatal Gastrointestinal Hemorrhage in a Child with Medulloblastoma on High Dose Dexamethasone.",
          "year": "2017",
          "relevance_score": 3.0,
          "polarity": "SUPPORTS",
          "match_reasons": []
        }
      ]
    },
    "6_contradictory_evidence": {
      "count": 0,
      "claims": []
    },
    "7_confidence_assessment": {
      "overall": "High",
      "dimensions": {
        "mechanistic_strength": "High",
        "literature_strength": "High",
        "clinical_evidence": "Medium"
      },
      "quality_scorecard": {
        "overall_score": 0.912,
        "decision": "finalize",
        "dimensions": {
          "completeness": {
            "score": 1.0,
            "reason": "5/5 sections present"
          },
          "evidence_support": {
            "score": 1.0,
            "reason": "1/1 claims have paper evidence"
          },
          "citation_validity": {
            "score": 1.0,
            "reason": "1 verified, 0 partial out of 1"
          },
          "mechanistic_specificity": {
            "score": 1.0,
            "reason": "1/1 claims reference targets"
          },
          "contradiction_handling": {
            "score": 0.3,
            "reason": "No contradiction analysis"
          },
          "traceability": {
            "score": 1.0,
            "reason": "1/1 claims have provenance"
          },
          "output_structure": {
            "score": 1.0,
            "reason": "Executive summary + confidence assessment"
          },
          "actionability": {
            "score": 1.0,
            "reason": "2 next steps, 2 data gaps identified"
          }
        },
        "weak_dimensions": [
          "contradiction_handling"
        ],
        "rerun_targets": []
      }
    },
    "8_risk_flags_limitations": {
      "risk_flags": [
        "Famotidine was suggested to be changed to lansoprazole for acid suppression in one case report, implying potential limitations or alternatives.",
        "One meta-analysis indicated lower safety for some treatments compared to placebo, though famotidine was not explicitly mentioned in this negative context."
      ],
      "limitations": [
        "The provided literature includes meta-analyses and case reports, but a dedicated, large-scale randomized controlled trial focusing solely on famotidine for duodenal ulcer treatment might be lacking.",
        "Some studies used famotidine as a comparator or in combination therapy, which may not fully reflect its efficacy as a standalone treatment."
      ],
      "missing_data": [
        "Direct comparison studies of famotidine versus other H2RAs or PPIs specifically for initial non-eradication treatment of duodenal ulcers.",
        "Detailed patient-level data from trials involving famotidine for duodenal ulcers."
      ]
    },
    "9_recommended_next_steps": {
      "clinical_next_steps": [
        "Conduct a prospective clinical trial comparing famotidine to standard-of-care treatments for duodenal ulcers.",
        "Evaluate the long-term efficacy and safety of famotidine in preventing duodenal ulcer recurrence."
      ]
    },
    "10_claim_evidence_table": {
      "total_claims": 1,
      "claims": [
        {
          "claim_id": "CLM-2d7963",
          "statement": "Famotidine's mechanism of action, as a histamine H2 receptor antagonist, is directly relevant to the treatment of duodenal ulcers by reducing gastric acid secretion.",
          "confidence_numeric": 0.9,
          "confidence_label": "HIGH",
          "polarity": "INCONCLUSIVE",
          "verification_status": "VERIFIED",
          "targets": [
            "HRH2"
          ],
          "citation_count": 4,
          "risk_flags": []
        }
      ]
    },
    "11_provenance_appendix": {
      "total_entries": 1,
      "entries": [
        {
          "claim_id": "CLM-2d7963",
          "source_agent": "SynthesisCriticAgent",
          "source_run": "37713d01deec",
          "timestamp": "2026-06-03T14:05:39.508295+00:00",
          "paper_evidence": [
            {
              "pmid": "39193965",
              "snippet": "Famotidine is a competitive histamine H-receptor antagonist that reduces the formation of stomach acid and is used to treat gastrointestinal disorders associated with acid reflux, gastroesophageal ref",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "35002587",
              "snippet": "In this study, we evaluated the protective effect of PNX-14 against the formation of experimental indomethacin (IND)-induced duodenal ulcer. Thirty-two\u200e male Sprague-Dawley rats were randomly assigned",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "31229990",
              "snippet": "After ulcer healing, we randomly assigned (1:1) patients to receive oral lansoprazole 30\u2009mg or famotidine 40\u2009mg daily for 24 months.",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            },
            {
              "pmid": "26883979",
              "snippet": "Preliminary screening of literature with the criteria of low toxicity led to four histamine-2 receptor antagonists (H2RAs): nizatidine, famotidine, lafutidine, and roxatidine acetate, which were selec",
              "polarity": "SUPPORTS",
              "verification": "VERIFIED",
              "error": null
            }
          ],
          "mechanism_evidence": [
            {
              "target": "HRH2",
              "action": "ANTAGONIST"
            }
          ],
          "queries_used_count": 11
        }
      ]
    }
  },
  "metadata": {
    "run_id": "37713d01deec",
    "created_at": "2026-06-03T14:05:15.754521+00:00",
    "drug": "FAMOTIDINE",
    "disease": "duodenal ulcer",
    "total_claims": 1,
    "quality_score": 0.9125,
    "reruns": 0
  }
}
```
